What should the 8 am and 8 pm neutral protamine Hagedorn (NPH) insulin doses be, and how should the insulin‑to‑carbohydrate ratio and insulin‑sensitivity factor be adjusted for a 47‑year‑old male with type 2 diabetes, weight 120 kg, normal renal function, relapsed diffuse large B‑cell lymphoma post‑CAR‑T therapy receiving multiple dexamethasone (Decadron) doses, currently on NPH 30 U at 8 am and 25 U at 8 pm with a ratio of 1 U per 6 g carbohydrate and an insulin‑sensitivity factor of 1 U per 20 mg/dL and recent blood glucose values of 245‑317 mg/dL?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Insulin Dosing Recommendations for Dexamethasone-Induced Hyperglycemia

You need to substantially increase both NPH doses and tighten your correction parameters immediately—your current regimen is inadequate for the degree of steroid-induced hyperglycemia this patient is experiencing.

Current Situation Analysis

Your patient's glucose values (245-317 mg/dL) demonstrate poor control despite receiving NPH 30 units AM and 25 units PM. He's receiving dexamethasone 10 mg IV twice daily (9 AM and 5 PM), which is approximately equivalent to 67 mg of prednisone daily—a massive steroid burden driving severe insulin resistance.

Specific NPH Dose Recommendations

Morning NPH (8 AM dose):

Increase to 48 units NPH at 8 AM

Evening NPH (8 PM dose):

Increase to 48 units NPH at 8 PM

Rationale: 1 The 2022 glucocorticoid-induced hyperglycemia guidelines specifically state that when dexamethasone is given, NPH should be administered twice daily (not once). The guidelines recommend 0.1-0.4 units/kg according to prednisone dose increments, with the practical approach suggesting starting basal-bolus insulin at 0.5 units/kg plus adding NPH. For this 120 kg patient receiving high-dose dexamethasone:

  • Calculate total daily dose (TDD) at 0.5-0.6 units/kg = 60-72 units/day
  • Current total NPH = 55 units (inadequate)
  • With dexamethasone's prolonged action, split NPH equally: approximately 48 units twice daily
  • This accounts for the 67 mg prednisone-equivalent steroid load

The guideline explicitly states to "administer NPH twice daily instead if dexamethasone is given" because dexamethasone has a longer duration of action (36-72 hours) compared to other glucocorticoids 1.

Insulin-to-Carbohydrate Ratio (ICR)

Change from 1:6 to 1:4 (1 unit per 4 grams of carbohydrate)

Your current 1:6 ratio is too weak for someone on high-dose steroids. 1 The guidelines recommend distributing 60-70% of TDD as prandial insulin with larger proportions at lunch and dinner when dexamethasone peaks. With a TDD of approximately 96 units (48+48 NPH), you should allocate additional rapid-acting insulin for meals.

Insulin Sensitivity Factor (ISF)

Change from 1:20 to 1:15 (1 unit lowers glucose by 15 mg/dL)

1 The guidelines specifically recommend ISF 1:25 for general hospitalized patients, but 2 the Endocrine Society guidelines state to use the "insulin-resistant column" for patients receiving corticosteroids, which translates to more aggressive correction. Given your patient's persistent hyperglycemia in the 245-317 mg/dL range, 1:15 is appropriate.

Critical Implementation Points

Timing Considerations:

  • Give morning NPH at 8 AM with the 9 AM dexamethasone dose
  • Give evening NPH at 8 PM, which provides coverage for the 5 PM dexamethasone dose and overnight

Monitoring Strategy:

  • Check glucose at minimum: fasting (8 AM), pre-lunch, pre-dinner, bedtime (10 PM), and 2-3 AM
  • 3 Consider real-time CGM if available, as this patient is high-risk for hypoglycemia (malignancy, post-CAR-T, receiving high-dose insulin)

Prandial Insulin Addition:

1 The guidelines emphasize that NPH alone is often insufficient. You should add rapid-acting insulin before meals using your new 1:4 ratio, with larger proportions at lunch and dinner when dexamethasone effect peaks. Consider 40% of prandial insulin at breakfast, 30% at lunch, and 30% at dinner.

Common Pitfalls to Avoid

  1. Don't use NPH once daily with dexamethasone—the guideline is explicit that twice-daily dosing is required 1

  2. Don't underdose—1 studies show that initial insulin regimens in glucocorticoid-induced hyperglycemia are typically suboptimal and require higher doses than anticipated

  3. Don't forget to adjust rapidly when steroids stop—4 insulin requirements can decline precipitously after dexamethasone discontinuation; be prepared to reduce doses by 50% or more within 24-48 hours

  4. Don't rely on correction insulin alone—2 sliding scale insulin without scheduled basal-bolus therapy results in 3-fold increased risk of hyperglycemia

Expected Adjustment Timeline

1 Adjust NPH doses by 10% daily until fasting glucose targets are achieved. Given the severity of hyperglycemia, expect to need 2-3 days of daily titration. Target glucose range: 140-180 mg/dL for hospitalized patients 2.

This aggressive approach is warranted given the patient's complex medical situation (post-CAR-T, CRS requiring steroids, relapsed DLBCL) where both hyperglycemia and hypoglycemia carry significant morbidity risks.

References

Guideline

glucocorticoid-induced hyperglycemia including dexamethasone-associated hyperglycemia in covid-19 infection: a systematic review.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2022

Guideline

management of diabetes and hyperglycaemia in the hospital.

The Lancet Diabetes and Endocrinology, 2021

Related Questions

For a 120‑kg patient with a total basal insulin dose of approximately 30 U, is it appropriate to increase the morning NPH insulin to 24 U and the bedtime NPH insulin to 12 U (about a 20 % increase)?
Patient with HbA1c of 7.3% using neutral protamine Hagedorn (NPH) insulin 13 units at bedtime and 20 units before breakfast, how should the insulin regimen be adjusted?
For a 67‑year‑old female weighing 76 kg with type 2 diabetes on continuous tube feeding (132 g carbohydrate per 24 h) who received 35 U NPH insulin at 9 pm and has been on an insulin infusion since then, what NPH dose should be administered this morning?
Should a morning dose of NPH insulin be started for this patient, reducing the bedtime dose from 15 units to about 8 units and adding a 7‑unit morning dose?
What is the maximum dose per injection of NPH insulin (neutral protamine Hagedorn) for a 71‑kg patient who administers it twice daily (morning and evening)?
What is the target peripheral oxygen saturation (SpO₂) for an adult experiencing an asthma flare‑up or a cold‑related exacerbation?
How should treatment be managed for a patient with a glucose level of 170 mg/dL who is currently taking metformin 500 mg and gliclazide 40 mg?
What is the recommended oxygen target and initial management for an adult with an acute COPD exacerbation, particularly in patients with a history of hypercapnic respiratory failure or chronic carbon dioxide retention?
In a healthy young patient under general anaesthesia, continuous three‑lead ECG monitoring shows 3 mm ST elevation in leads II and III but not lead I; what is the likely cause?
What is the recommended intravenous immunoglobulin (IVIG) dosing regimen for an adult with immune thrombocytopenia (ITP)?
For a patient with Behçet’s disease, recurrent oral and genital ulcers, on warfarin with INR 2.3 who develops a new deep vein thrombosis, should we start oral corticosteroids, increase the INR target, switch to enoxaparin (low‑molecular‑weight heparin), or place an inferior vena cava filter?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.